Molecular signaling mechanisms of renal gluconeogenesis in nondiabetic and diabetic conditions

@article{Swe2019MolecularSM,
  title={Molecular signaling mechanisms of renal gluconeogenesis in nondiabetic and diabetic conditions},
  author={Myat Theingi Swe and Anchalee Pongchaidecha and Varanuj Chatsudthipong and Nipon Chattipakorn and Anusorn Lungkaphin},
  journal={Journal of Cellular Physiology},
  year={2019},
  volume={234},
  pages={8134 - 8151}
}
The kidneys are as involved as the liver in gluconeogenesis which can significantly contribute to hyperglycemia in the diabetic condition. Substantial evidence has demonstrated the overexpression of rate‐limiting gluconeogenic enzymes, especially phosphoenolpyruvate carboxykinase and glucose 6 phosphatase, and the accelerated glucose release both in the isolated proximal tubular cells and in the kidneys of diabetic animal models and diabetic patients. The aim of this review is to provide an… 

Renal gluconeogenesis in insulin resistance: A culprit for hyperglycemia in diabetes

Overall, the available literature suggests that impairment in renal gluconeogenesis in an insulin-resistant state may contribute to hyperglycemia in type 2 diabetes.

Characterization of Enlarged Kidneys and Their Potential for Inducing Diabetes in DEK Rats

Findings indicate that enlarged kidneys were associated with the onset of diabetes and with the resistance to diabetic nephropathy in DEK-DM, and indicate that the kidneys are therapeutic targets to prevent T2D.

Glucose transporters in the kidney in health and disease

  • V. Vallon
  • Biology, Medicine
    Pflügers Archiv - European Journal of Physiology
  • 2020
Enhanced glucose reabsorption is coupled to sodium retention through the sodium-glucose cotransporter SGLT2, which induces secondary deleterious effects, and as a consequence, S GLT2 inhibitors are new anti-hyperglycemic drugs that can protect the kidneys and heart from failing.

Renal Tubular Handling of Glucose and Fructose in Health and Disease.

SGLT2 inhibitors are new anti-hyperglycemic drugs that can protect the kidneys and heart from failing independent of kidney function and diabetes and are linked to potentially detrimental aerobic glycolysis (Warburg effect).

The role of metabolic reprogramming in tubular epithelial cells during the progression of acute kidney injury

It is confirmed that targeting metabolic reprogramming in PTCs represents a potentially effective therapeutic strategy for the progression of AKI, andDeranged FAO and enhanced glycolysis may contribute to the AKI to CKD transition through different molecular biological mechanisms.

Acid Loading Unmasks Glucose Homeostatic Instability in Proximal-Tubule-Targeted Insulin/Insulin-Like-Growth-Factor-1 Receptor Dual Knockout Mice.

An important role is demonstrated for insulin and/or IGF1 receptor signaling in the PT to facilitate this process and reduce excursions in blood glucose in type 2 diabetes especially when coupled with metabolic acidosis.

Electrolyzed hydrogen-rich water for oxidative stress suppression and improvement of insulin resistance: a multicenter prospective double-blind randomized control trial

There were no significant effect of EHW in the change in HOMA-IR in this study; larger-scale and longer-term study are needed to verify the effects of EhW in T2DM patients.

References

SHOWING 1-10 OF 110 REFERENCES

Intrinsic gluconeogenesis is enhanced in renal proximal tubules of Zucker diabetic fatty rats.

These data provide the first demonstration in an animal model that renal gluconeogenesis is upregulated by a long-term mechanism during type 2 diabetes and lend support to the view so far based only on in vivo studies performed in humans that kidneys may be stimulated by and crucially contribute to the hyperglycemia of type 1 diabetes.

Angiotensin receptor blocker telmisartan suppresses renal gluconeogenesis during starvation

The increased renal SGLT2 expression, elevated renal gluconeogenesis enzymes and extent of insulin-resistance in the DM rats were ameliorated by telmisartan therapy, thus resulting in decreased plasma glucose levels after 24 hours of fasting.

Dual Regulation of Gluconeogenesis by Insulin and Glucose in the Proximal Tubules of the Kidney

It is suggested that both insulin signaling and glucose reabsorption suppress the gluconeogenic gene expression by inactivation of FoxO1 and PGC1α, respectively, providing insight into novel mechanisms underlying the regulation of gluconeogenesis in the PTs.

Renal glucose metabolism in normal physiological conditions and in diabetes.

Kidney: its impact on glucose homeostasis and hormonal regulation.

  • A. Mitrakou
  • Biology, Medicine
    Diabetes research and clinical practice
  • 2011

Renal glucose production and utilization: new aspects in humans

Recent studies have refuted the view that the liver is the exclusive site of glucose production in humans in the postabsorptive state by combining isotopic and balance techniques, and demonstrated that renal glucose production accounts for 25 % of systemic glucose production.

The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia

Although the long‐term efficacy and safety of SGLT2 inhibitors remain under study, the class represents a novel therapeutic approach with potential for the treatment of both type 2 and 1 diabetes.

Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus.

It is concluded that in type 2 diabetes, both liver and kidney contribute to glucose overproduction and that renal glucose uptake is markedly increased, which may suppress renal FFA uptake via a glucose-fatty acid cycle and explain the accumulation of glycogen commonly found in the diabetic kidney.

H+-ATPase blockade reduced renal gluconeogenesis and plasma glucose in a diabetic rat model

The suppression of renal gluconeogenesis by an H+-ATPase inhibitor may be a new therapeutic target for the treatment of diabetes mellitus.

Predominant Role of Gluconeogenesis in Increased Hepatic Glucose Production in NIDDM

It is concluded that increased gluconeogenesis is the predominant mechanism responsible for increased hepatic glucose output in NIDDM.
...